Myeloid and Lymphoid Neoplasms with Eosinophilia and Abnormalities of PDGFRA, PDGFRB or FGFR1

E-ISSN： 1875-6301|8|1|44-51

ISSN： 1573-3947

Source： Current Cancer Therapy Reviews, Vol.8, Iss.1, 2012-02, pp. : 44-51

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sorafenib is effective for imatinib-resistant FIP1L1/PDGFRA T674I mutation-positive acute myeloid leukemia with eosinophilia

By Al-Riyami Arwa Z.

Leukemia and Lymphoma, Vol. 54, Iss. 8, 2013-08 ,pp. : 1788-1790

Informa Healthcare

Access to resources Recommend Favorite

BCR-ABL1-negative chronic myeloid neoplasms: an update on management techniques

By Vannucchi Alessandro M Pieri Lisa Susini Maria Chiara Guglielmelli Paola

Future Oncology, Vol. 8, Iss. 5, 2012-05 ,pp. : 575-593

Future Medicine

Access to resources Recommend Favorite

Alemtuzumab in CLL and Other Lymphoid Neoplasms

By Ravandi Farhad O'Brien Susan

Cancer Investigation, Vol. 24, Iss. 7, 2006-09 ,pp. : 718-725

Informa Healthcare

Access to resources Recommend Favorite

Recurrent CEP85L-PDGFRB fusion in patient with t(5;6) and imatinib-responsive myeloproliferative neoplasm with eosinophilia

By Winkelmann Nils

Leukemia and Lymphoma, Vol. 54, Iss. 7, 2013-07 ,pp. : 1527-1531

Informa Healthcare

Access to resources Recommend Favorite

By Melichar Bohuslav Laco Jan Fridrichová Petra Šimkovičč Martin Papajík Tomáš Foretová Lenka

Acta Oncologica, Vol. 51, Iss. 1, 2012-01 ,pp. : 136-138

Informa Healthcare

Access to resources Recommend Favorite